id: NEW:phenobarbital_treatment_protocol_to_NEW:hospital_length_of_stay_aws
name: Phenobarbital Treatment Protocol for Alcohol Withdrawal â†’ Hospital Length of Stay for Alcohol Withdrawal
  Syndrome
from_node:
  node_id: NEW:phenobarbital_treatment_protocol
  node_name: Phenobarbital Treatment Protocol for Alcohol Withdrawal
to_node:
  node_id: NEW:hospital_length_of_stay_aws
  node_name: Hospital Length of Stay for Alcohol Withdrawal Syndrome
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Chronic alcohol use leads to downregulation of GABA receptors in the brain'
- 'Step 2: Downregulated GABA receptors often cause benzodiazepine resistance in alcohol withdrawal patients'
- 'Step 3: Phenobarbital acts on GABA-A receptors through a different mechanism than benzodiazepines'
- 'Step 4: More effective GABA modulation leads to faster stabilization of withdrawal symptoms'
- 'Step 5: Faster clinical stabilization results in reduced hospital length of stay'
evidence:
  quality_rating: B
  n_studies: 4
  primary_citation: 'Zaryab Umar et al. 2023. "Phenobarbital and Alcohol Withdrawal Syndrome: A Systematic
    Review and Meta-Analysis." https://doi.org/10.7759/cureus.33695'
  supporting_citations:
  - Additional citations require full-text access - abstract references studies included in meta-analysis
    but does not name them specifically
  - Studies comparing phenobarbital to benzodiazepines in ICU settings (referenced in methodology)
  - Studies measuring alcohol withdrawal scoring systems (referenced in outcomes)
  doi: 10.7759/cureus.33695
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Phenobarbital use in alcohol withdrawal syndrome management is associated with statistically
  significant reduction in hospital length of stay compared to benzodiazepine-only treatment, with a mean
  difference of 2.6 fewer days. This is particularly relevant for patients with benzodiazepine resistance
  due to GABA receptor downregulation from chronic alcohol use.
quantitative_effects:
  effect_size:
    value: -2.6
    type: standardized_mean_difference
    ci_lower: -4.48
    ci_upper: -0.72
  p_value: 0.007
moderators:
- name: symptom_severity
  direction: strengthens
  strength: moderate
  description: Paper notes drug administration should be adapted according to symptom severity, suggesting
    differential effectiveness based on withdrawal severity
- name: phenobarbital_dosing_protocol
  direction: strengthens
  strength: moderate
  description: Lack of uniformity in phenobarbital dosing across studies may moderate effectiveness; standardized
    protocols may improve outcomes
structural_competency:
  equity_implications: This mechanism relates to healthcare system protocols and treatment accessibility.
    Patients with alcohol use disorder often face structural barriers including limited access to specialized
    addiction medicine, stigma in healthcare settings, and lack of standardized treatment protocols. The
    availability of phenobarbital as an alternative treatment option represents a structural healthcare
    intervention that can reduce healthcare costs and improve outcomes for a vulnerable population that
    frequently experiences healthcare discrimination.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:36.339661'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
